Safety and Efficacy of Herbal Tea in Type 2 Diabetics
DIABHerbMix
Safety and Efficacy of a Complex Herbal Tea Mixture in Type 2 Diabetics
1 other identifier
interventional
60
1 country
3
Brief Summary
Nearly 25% of the world's population relies on traditional medicinal systems but for professionals their effectiveness and even more safety are the main concern. Therefore, the aim of this preliminary study is to assess safety and effectiveness of herbal tea mixture on the control of glycaemia in Type 2 diabetics.The mixture consists of nine plants which have well-documented traditional use for the control of glycaemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Jul 2019
Shorter than P25 for not_applicable type-2-diabetes
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 29, 2019
CompletedFirst Posted
Study publicly available on registry
August 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2020
CompletedFebruary 13, 2020
February 1, 2020
7 months
July 29, 2019
February 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with adverse event
Adverse event (e.g. hypoglycaemia) reporting through direct contact researcher-patient.
Starting from baseline, once per week until study completion at week 12.
Secondary Outcomes (2)
Glycated Hemoglobin
At enrollment (baseline) and at the end of the intervention (at 12 weeks).
Fasting Glucose
At enrollment (baseline) and at the end of the intervention (at 12 weeks).
Other Outcomes (10)
Creatinine
At enrollment (baseline) and at the end of the intervention (at 12 weeks).
Urea
At enrollment (baseline) and at the end of the intervention (at 12 weeks).
Total Proteins
At enrollment (baseline) and at the end of the intervention (at 12 weeks).
- +7 more other outcomes
Study Arms (2)
Intervention
EXPERIMENTALHerbal Tea Mixture is consisted of: Vaccinium myrtillus L. folium, Morus nigra L. folium, Phaseolus vulgaris L. pericarpium, Viscum album L. herba, Urtica dioica L. radix, Gentiana lutea L. radix, Taraxacum officinale W. radix, Cichorium intybus L. herba, Teucrium chamaedrys L. herba, Stevia rebaudiana folium.
Control
ACTIVE COMPARATORHerbal Tea Mixture without antidiabetic properties is consisted of: Achillea millefolium L. herba, Teucrium montanum L. herba, Glechoma hederacea L. herba, Eupatorium cannabinum L. herba, Humulus lupulus L. lupulin, Artemisia absinthium L. herba, Salvia officinalis L.
Interventions
Patients will be instructed to take 250 mL of freshly prepared tea (1 tea spoon or 3 g of tea, pour over 250 mL of boiling water and leave aside for 15 min) 2 times per day during 12 weeks. The first tea needs to be taken in the morning prior any meal. The second can be taken at any time during the day but with at least 4 hour difference from the first cup.
Patients will be instructed to take 250 mL of freshly prepared tea (1 tea spoon or 3 g of tea, pour over 250 mL of boiling water and leave aside for 15 min) 2 times per day during 12 weeks. The first tea needs to be taken in the morning prior any meal. The second can be taken at any time during the day but with at least 4 hour difference from the first cup.
Eligibility Criteria
You may qualify if:
- signed informed consent
- Croatian-speaking
- stable therapy for at least 3 months prior enrollment
- not taking any dietary supplements, especially herbal-based
- not taking any other herbal medicine (as a tea or a supplement)
- stable dietary and lifestyle patterns for at least 3 months prior enrollment
You may not qualify if:
- type 1 diabetes
- severe somatic disorder (oncological disease, hepatic, renal or autoimmune disease)
- pregnancy
- inability to fill in questionnaires in Croatian
- cognitive impairment
- psychiatric disorder
- undergoing current treatment for a major medical illness such as malignancy, autoimmune or immune deficiency disorder
- clotting disorders
- having nutritional deficiency (e.g. iron deficiency)
- current or history of eating disorder (anorexia, bulimia or EDNOS)
- current use of weight loss interventions (drugs; exercise interventions)
- regular use of dietary supplements, especially herbal-based
- regular use of herbal medicine (as a tea or a supplement)
- significant changes in diet or lifestyle patterns (e.g. increased physical activity) in the last 3 months prior the enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Josip Juraj Strossmayer University of Osijeklead
- Dom zdravlja Osijek (Health Centre Osijek)collaborator
- Osijek University Hospitalcollaborator
Study Sites (3)
Department of Food and Nutrition Research, Faculty of Food Technology
Osijek, 31000, Croatia
Health Centre Osijek
Osijek, 31000, Croatia
University Hospital Centre
Osijek, 31000, Croatia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ines Banjari, PhD
Department of Food and Nutrition Research, Faculty of Food Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Prof. Dr.
Study Record Dates
First Submitted
July 29, 2019
First Posted
August 13, 2019
Study Start
July 1, 2019
Primary Completion
February 10, 2020
Study Completion
February 12, 2020
Last Updated
February 13, 2020
Record last verified: 2020-02